In the assessment of medicines, the MEB puts the patient’s interests first.
- What does a patient information leaflet contain?
- Be careful with certain ingredients in medicines
- Unbranded medicines
- With or without a prescription?
- Safe use of medicines without prescription
- Influenza vaccine
In-use shelf life to be listed on packaging of over-the-counter medicinal products
The Medicines Evaluation Board (MEB) wants manufacturers of over-the-counter medicinal products to list the in-use shelf life...
MEB confirms current legal status of supply ibuprofen 200 mg
The Medicines Evaluation Board (MEB) has evaluated whether the recent European review of the adverse events on heart and blood...
Domperidone suppositories no longer available
It is with regret that the Medicines Evaluation Board (MEB) takes note of the news that Motilium (domperidone) 30 mg...
CBG viewpoint Onglyza (saxagliptine)
The safety of the diabetes treatment Onglyza (saxagliptin) is currently the focus of attention. The reason for this is an...
Conditional marketing authorisation Thiosix (tioguanine)
The Medicines Evaluation Board (MEB) has decided this afternoon to award a conditional marketing authorisation for the...